
Bottle with pills euthanasia viagra alternative analgesics antibiotics care istock photo for BL | Photo Credit: artisteer
Torrent Pharma Shares, JB Chemicals & Pharmaceuticals Share Price Live Updates: Torrent Pharmaceuticals on Sunday announced the acquisition of a controlling stake in JB Chemicals & Pharmaceuticals from KKR for a purchase price of up to ₹19,480 crore, translating into an equity valuation of ₹25,689 crore.
The acquisition will be followed by a merger of JB Chemicals with Torrent Pharmaceuticals, a joint statement said.
Shares of Torrent Pharmaceuticals gained nearly 4 per cent in early trade on Monday, while JB Chemicals & Pharmaceuticals tanked 7 per cent.
Scroll down for more
- 15:08 | June 30, 2025
JB Chemicals, Torrent Pharma share price live: Shares in focus nearly 25 minutes ahead of market close
JB Chemicals stock traded 6.60% lower on the NSE at ₹1,682.50, while Torrent Pharma rose 2.04% to ₹3,409.70 as at 3.07 pm.
- 14:50 | June 30, 2025
JB Chemicals share price live: Shares down 6.46% on the NSE as at 2.50 pm; mcap stood at ₹26,295.93 cr
- 14:28 | June 30, 2025
Torrent Pharmaceuticals share price live: Shares up 2%
Shares of Torrent Pharmaceuticals rose 2.42% on the NSE to ₹3,422.30 as at 2.27 pm. Its mcap stood at ₹1.15 lakh crore.
- 14:11 | June 30, 2025
JB Chemicals share price live: Shares tank 6.84% on the NSE to ₹1,678.20
- 14:10 | June 30, 2025
JB Chemicals share price live: Merger valuation rationale
Merger valuation rationale
The swap ratio has been recommended by Ernst and Young Merchant Banking Services LLP (for Torrent) and BDO Valuation Advisory LLP (for JB Pharma) and the fairness opinion on the same has been issued by ICICI Securities for JB Pharma o JB Pharma shareholdersto get 51 equity shares of Torrent for every 100 equity shares of JB Pharma
(Investor presentation)
- 13:32 | June 30, 2025
Torrent Pharma share price live: Shares up nearly 2%
Shares of Torrent Pharma rose 1.76% on the BSE to ₹3,403.25 as at 1.30 pm.
- 13:19 | June 30, 2025
Stock market live updates today: Mid-market | Sensex down 450 points; PSU Bank index up 2%, SBI, Bank of Maharashtra, PNB, Union Bank shares up
Sensex tanked 455.58 points or 0.54 per cent to 83,603.32 as at 1 pm, against the previous close of 84,058.90, and Nifty 50 depreciated by 125.60 points or 0.49 per cent to 25,512.20.
Shares of Bank of Maharashtra, Union Bank, PNB, Canara Bank and Bank of Baroda gained 3-4 per cent, leading the gainers on the index.
Shares of State Bank of India, Shriram Finance, Jio Financial, Bharat Electronics, HDFC Life and Eternal gained 1-2 per cent among the Nifty 50 pack, while Tata Consumer Products, Dr Reddy’s Laboratories, Hero Motocorp, Maruti and Apollo Hospitals declined 1-3 per cent.
- 13:05 | June 30, 2025
JB Chemicals share price live today: Shares trade 6% lower, top losers on the BSE
JB Chemicals stock traded 6.30% lower on the BSE at ₹1,685.95 as at 1.03 pm
- 12:09 | June 30, 2025
Torrent Pharma share price live today, JB Chemicals acquisition: Shares gain
Torrent Pharma shares rose 1.49% on the NSE to ₹3,391.20 as at 12.089 pm.
- 11:48 | June 30, 2025
Torrent Pharma to acquire controlling stake in JB Chem and Pharma
Torrent Pharmaceuticals said on Sunday it will acquire a 46.39 per cent of controlling stake in smaller peer JB Chemicals and Pharmaceuticals from New York-based investment firm KKR, and plans to merge the two drugmakers.
The transaction, announced in a joint statement released by the three companies, implies a total equity valuation of ₹25,689 crores($3.01 billion) for JB Pharma on a fully diluted basis.
“This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market, and building a larger diversified global presence,” Torrent Executive Chairman Samir Mehta said in the statement.
Under the terms of the deal, Torrent will initially acquire an equity stake in JB Pharma from KKR for ₹11,917 crore
- 11:18 | June 30, 2025
Torrent Pharma share price live today, JB Chemicals acquisition: Shares flat
Shares of Torrent Pharma traded flat on the NSE at ₹3,343.50 as at 11.17 am.
- Day’s high: ₹3,478.90
- Day’s low: ₹3.,322
- Day’s open: ₹3,416
- Previous close: ₹3,341.40
- 10:52 | June 30, 2025
JB Chemicals & Torrent Pharma share price live today: JB Chemicals stock plunges 7%
JB Chemicals stock plunged 6.56% on the NSE to ₹1,683.20 as at 10.51 am, hitting a low of ₹1,673.
- 10:50 | June 30, 2025
JB Chemicals & Torrent Pharma share price live today: Exchange disclosure on acquisition
Torrent Pharmaceuticals has announced an Open Offer to acquire up to 4,17,45,264 fully-paid-up equity shares of face value ₹1 each from the Eligible Shareholders of the Target Company, representing 26.00 % of of JB Chemicals, at a price ₹1,639.18 per Equity Share.
NovaaOne Capital Pvt Ltd has been appointed as the manager to the Open Offer.
- 10:27 | June 30, 2025
Torrent Pharma share price live, JB Chemicals acquisition: HSBC maintains buy on Torrent Pharma
HSBC on Torrent Pharma
Maintain Buy with target price of Rs 3,775
- Torrent to acquire controlling stake in JB Pharma
- Deal will boost Torrent’s standing in chronic therapies in India and also add international CDMOs capabilities
- Believe this deal offers next leg of growth for Torrent and we wait for deal closure.
- Acquisition Not A Surprise; Inorganic Expansion, Particularly In India Has Been Torrent’s Strategy
- Deal Size Will Be Much Larger Than What Torrent Has Executed In The Past
- Impact On Torrent’s Earnings Likely To Be Negative Given Rising Interest Charges & Amortisation
- 10:08 | June 30, 2025
Torrent pharma & JB Chemicals stock price live today, Torrent Pharma share price live, JB Chemicals acquisition: Nomura maintains neutral call on Torrent Pharma at ₹3,580 TP
Nomura on Torrent Pharma
Maintain Neutral with target price of Rs 3,580
- Acquisition will not be a surprise to us, as inorganic expansion, particularly in India, has been a key strategy for Torrent
- Investors are likely to take comfort that Torrent has been successful in past acquisitions as they have been value accretive
- In the case of JB, the India product portfolio is complementary to that of Torrent
- 09:43 | June 30, 2025
Torrent pharma & JB Chemicals stock price live today: JB Chemicals stock down 6%
JB Chemicals stock fell 6.47% on the NSE to ₹1,684.90 as at 9.42 am, hitting a low of ₹1,673 against the previous close of ₹1,801.40.
- 09:42 | June 30, 2025
Torrent pharma & JB Chemicals stock price live today: Torrent Pharma shares trade flat
Shares of Torrent Pharma traded flat on the NSE at ₹3,352.40 as at 9.41 am after soaring to a high of ₹3,478.90. It opened at ₹3,416 against the previous close of ₹3,341.40.
- 09:40 | June 30, 2025
Torrent pharma & JB Chemicals stock price live today: 5 Pharma stocks that will see some action today
- Torrent Pharmaceuticals
- JB Chemicals & Pharmaceuticals
- Alembic Pharmaceuticals, and more
- 09:39 | June 30, 2025
Torrent pharma & JB Chemicals stock price live today: Torrent Pharma to acquire controlling stake in JB Chemicals & Pharmaceuticals from KKR
Torrent Pharmaceuticals on Sunday announced the acquisition of a controlling stake in JB Chemicals & Pharmaceuticals from KKR for a purchase price of up to ₹19,480 crore, translating into an equity valuation of ₹25,689 crore.
The acquisition will be followed by a merger of JB Chemicals with Torrent Pharmaceuticals, a joint statement said.
The Ahmedabad-based flagship company of the Torrent Group stated that the transaction will be executed in two phases. The acquisition of 46.39 per cent equity stake (on a fully diluted basis) through a Share Purchase Agreement at a consideration of ₹11,917 crore (₹1,600 per share) followed by a mandatory open offer to acquire up to 26 percent of JB Pharma shares from public shareholders at an open offer price of ₹1,639.18 per share, the company stated in an official release. In addition to the above, Torrent has also expressed its intent to acquire up to 2.80 per cent of equity shares from certain employees of JB Pharma at the same price per share as KKR.
Published on June 30, 2025
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.